Longevity finance

AI

Selfie biomarkers: AI and insurtech implications for Longevity

AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...
Danny Sullivan - 0
Read more
Independent living

L&G escalates investment into research for social care

UK's fragile social care system gets an essential boost from Legal & General. The UK has been facing a social care crisis for some time,...
Carla Heyworth - 0
Read more
Investment

Talking Longevity investment and risk with R42 Group

Longevity investment is growing and we're seeing a mixture of funds and investment platforms. We chat with the founder of R42 Group. R42 Group actively invents...
Phil Newman - 0
Read more
Longevity finance

Megatrends: longer lives and finance sector disruption

Financing Longevity means getting to grips with a collision of megatrends and surfing the Silver Tsunami. In the second of our two-part interview with Margaretta Colangelo, we...
Phil Newman - 0
Read more
Longevity finance

From health span to wealth span

Longevity industry expert Margaretta Colangelo says we are on the brink of a Longevity financial revolution. With people living longer and healthier lives than ever...
Phil Newman - 0
Read more
ChromaDex TruNiagen
whoop

Latest articles

TISSUE/ORGAN | NANOTECH | SENESCENCE | CELLULAR | DRUGS | AI | NEURAL | AGETECH | INVESTMENT

LONGEVITY MARKET | ABOUT US | MY ACCOUNT | SHARE YOUR NEWS | CONTACT US

PRIVACY POLICY | COOKIE POLICY | TERMS AND CONDITIONS | COPYRIGHT POLICY

© Copyright 2020 PERGALI Limited. All rights reserved. PERGALI, Longevity.Technology and their associated logos are trademarks of PERGALI Limited and are the subject of trademark applications or registrations in various countries around the world. All other trademarks are the property of their respective owners. All PERGALI products and services are subject to continuous development. We reserve the right to alter technical specifications without prior notice.